Author

Mathurin Flamant 1

1 Clinique Jules Verne,Nantes,France

IS THE CDMRIS USEFUL TO MONITOR PATIENTS WITH CROHN’S DISEASE BY MAGNETIC RESONANCE IMAGING?

Catherine Le Berre, Milène Tahora, Caroline Trang, Mathurin Flamant, Philippe Hallouin, Stanislas Bruley des Varannes, Arnaud Bourreille, Eric Frampas

POST-OPERATIVE COMPLICATIONS ARE NOT DECREASED BY A PROLONGED NUTRITIONAL SUPPORT IN PATIENTS WITH IBD OPERATED FOR A PERFORATING DISEASE

Marion Charvin, Mathurin Flamant, Guillaume Meurette, Caroline Trang, Emilie Duchalais, Paul-Antoine Lehur, Stanislas Bruley Des Varannes, Arnaud Bourreille

PRIMARY STUDY RESULTS FROM GO OBSERVE: A REAL-WORLD EUROPEAN PROSPECTIVE SINGLE-ARM OBSERVATIONAL COHORT STUDY OF PATIENT-REPORTED CONTINUOUS CLINICAL RESPONSE TO GOLIMUMAB IN ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Marc Ferrante, Anja Schirbel, Marieke J. Pierik, Thomas Haas, Mathurin Flamant, Tony Terzis, Ahmed Khalifa, George Philip, Freddy Cornillie, Alan Meehan, Marinella Govoni

SMALL BOWEL PREPARATION IN PATIENTS WITH CROHN'S DISEASE: THE POLYETHYLENE-GLYCOL IS NO LONGER USEFUL

LUDOVIC LAGIN, Arnaud Bourreille, Mathurin Flamant, Marie Freyssinet, Catherine Le Berre, Stanislas Bruley des Varannes, Caroline Trang

TERMINAL ILEITIS IN ADULT PATIENTS WITH CROHN’S DISEASE: IS SURGERY POSSIBLE AS FIRST-LINE THERAPY?

Florence Soufflet, Olivier Maillard, Caroline Trang, Guillaume Meurette, Stanislas Bruley Des Varannes, Mathurin Flamant, Arnaud Bourreille

WHICH SECOND-LINE BIOLOGIC AFTER ANTI-TNF FAILURE DURING CROHN'S DISEASE: USTEKINUMAB OR VEDOLIZUMAB, A MULTICENTRE RETROSPECTIVE STUDY

Cassandra Rayer, Xavier Roblin, David Laharie, Mathurin Flamant, Marie Dewitte, Mathurin Fumery, Benedicte Caron, Stéphanie Viennot, Benjamin Pariente, Laurent Siproudhis, Laurent Peyrin-Biroulet, Guillaume Bouguen

Item 1 - 6 / 15
1
2